标题
HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma
作者
关键词
-
出版物
VIRCHOWS ARCHIV
Volume 461, Issue 5, Pages 521-530
出版商
Springer Nature
发表日期
2012-10-02
DOI
10.1007/s00428-012-1321-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
- (2011) Maria D. Begnami et al. JOURNAL OF CLINICAL ONCOLOGY
- Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma
- (2011) Mikiko Takikita et al. Journal of Translational Medicine
- Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
- (2011) J. T. Garrett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors
- (2009) M. Sun et al. CLINICAL CANCER RESEARCH
- The Expression of Phospho-AKT, Phospho-mTOR, and PTEN in Extrahepatic Cholangiocarcinoma
- (2009) J.-Y. Chung et al. CLINICAL CANCER RESEARCH
- Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder
- (2009) Nafis Shafizadeh et al. HUMAN PATHOLOGY
- HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells
- (2009) Marta Soler et al. INTERNATIONAL JOURNAL OF CANCER
- EGFR and HER2 expression in advanced biliary tract cancer
- (2009) Jan Harder et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Lapatinib/Gemcitabine and Lapatinib/Gemcitabine/Oxaliplatin
- (2008) Howard Safran et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study
- (2008) T André et al. BRITISH JOURNAL OF CANCER
- The ERBB3 receptor in cancer and cancer gene therapy
- (2008) G Sithanandam et al. CANCER GENE THERAPY
- A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy
- (2008) S. T. Lee-Hoeflich et al. CANCER RESEARCH
- HER3 Is a Determinant for Poor Prognosis in Melanoma
- (2008) M. Reschke et al. CLINICAL CANCER RESEARCH
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study
- (2008) M Hofmann et al. HISTOPATHOLOGY
- Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells
- (2008) Yoko Ueno et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now